← Portfolio Scout

Portfolio company

COUR Pharma

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

3 investors

Sectors

Deep TechDigital Health

About

This clinical-stage biotechnology company develops nanoparticle therapies designed to restore immune tolerance for patients with autoimmune and inflammatory diseases.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies